As a complementary approach, multispectral immunofluorescence staining was carried out on tumor tissues derived from the 1222 PDX model, which revealed that the combination treatment inhibited RB phosphorylation in a large fraction of tumor cells as compared to the vehicle treated tumor (Fig. 9G). The gene discussed is RB1; the disease is neoplasm.